Case Reports
doi: 10.4088/jcp.v62n0413e.
Successful treatment of nondelusional body dysmorphic disorder with olanzapine: a case report
- PMID: 11379848
- DOI: 10.4088/jcp.v62n0413e
Item in Clipboard
Case Reports
Successful treatment of nondelusional body dysmorphic disorder with olanzapine: a case report
J Clin Psychiatry.
2001 Apr.
No abstract available
Similar articles
-
Open-label olanzapine in obsessive-compulsive disorder refractory to antidepressant treatment.Eur Psychiatry. 2002 Sep;17(5):296-7. doi: 10.1016/s0924-9338(02)00673-9. Eur Psychiatry. 2002. PMID: 12381502 Clinical Trial. No abstract available.
-
Olanzapine-sertraline combination in schizophrenia with obsessive-compulsive disorder.J Clin Psychiatry. 2003 May;64(5):611. doi: 10.4088/jcp.v64n0518c. J Clin Psychiatry. 2003. PMID: 12755669 No abstract available.
-
Effectiveness of olanzapine treatment for severe obsessive-compulsive disorder.Am J Psychiatry. 1999 Nov;156(11):1834-5. Am J Psychiatry. 1999. PMID: 10553756 No abstract available.
-
[Olanzapine. A new antipsychotic agent].Ugeskr Laeger. 1997 Nov 24;159(48):7160-4. Ugeskr Laeger. 1997. PMID: 9417725 Review. Danish. No abstract available.
-
Refractory obsessive-compulsive disorder: state-of-the-art treatment.J Clin Psychiatry. 2002;63 Suppl 6:20-9. J Clin Psychiatry. 2002. PMID: 12027116 Review.
Cited by
-
Body dysmorphic disorder.Dialogues Clin Neurosci. 2010;12(2):221-32. doi: 10.31887/DCNS.2010.12.2/abjornsson. Dialogues Clin Neurosci. 2010. PMID: 20623926 Free PMC article. Review.
-
Recognizing and treating body dysmorphic disorder.Ann Clin Psychiatry. 2005 Oct-Dec;17(4):205-10. doi: 10.1080/10401230500295313. Ann Clin Psychiatry. 2005. PMID: 16402752 Free PMC article. Review.
-
Off-label indications for atypical antipsychotics: A systematic review.Ann Gen Hosp Psychiatry. 2004 Feb 18;3(1):4. doi: 10.1186/1475-2832-3-4. Ann Gen Hosp Psychiatry. 2004. PMID: 14975068 Free PMC article.
-
Critical Review of the Use of Second-Generation Antipsychotics in Obsessive-Compulsive and Related Disorders.Drugs R D. 2018 Sep;18(3):167-189. doi: 10.1007/s40268-018-0246-8. Drugs R D. 2018. PMID: 30171515 Free PMC article. Review.
-
Olanzapine augmentation of fluoxetine in body dysmorphic disorder.Am J Psychiatry. 2005 May;162(5):1022-3. doi: 10.1176/appi.ajp.162.5.1022-a. Am J Psychiatry. 2005. PMID: 15863817 Free PMC article. Clinical Trial. No abstract available.